Giving antibodies 'eyes' may help target hidden KRAS mutations in cancer cells

Дата публикации: 24-07-2026 16:20:01

Antibodies are like "guided missiles" that find and attack cancer cells, but cancer-causing mutations inside cells have remained a "blind spot" for treatment because antibodies cannot reach them. KAIST researchers have now succeeded in precisely targeting intracellular cancer mutations using a newly designed antibody created through computational methods.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Researchers uncover 'hidden key' to immunotherapy for intractable brain tumors	2	8	20-07-2026
2	Helical nanoparticles trigger cancer alarms and deliver gene therapy	0	5.41	28-07-2026
3	Autoantibodies could shape cancer risk, growth and response to immunotherapy	0	9.66	25-07-2026
4	Redesigned lung cancer drug matches tumor control with fewer off-target interactions	0	9.72	24-07-2026
5	CRISPR makes prostate cancer vulnerable to immunotherapy	0	7.67	26-07-2026
6	Anticancer 'nanoswitch' technology shows promise in animal model of triple-negative breast cancer, colorectal cancer	5	7	10-07-2026
7	Researchers discover novel SRV2 envelope protein for efficient CAR immune cell production	5	7	01-07-2026
8	روبوتات ترصد الخلايا السرطانية "الصامدة" بعد العلاج	0	7	16-06-2026
9	New blood test for noncoding RNA significantly improves cancer detection	7	8	31-08-2023
10	Proalt desarrolla anticuerpos de precisión para transformar el tratamiento del cáncer metastásico	5	7	22-06-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 8.03. Источник: medicalxpress.com.